Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

Eitemau Tebyg

• Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe
  gan: Öner, D, et al.
  Cyhoeddwyd: (2024)
• T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
  gan: Salaun, B, et al.
  Cyhoeddwyd: (2023)
• Respiratory Syncytial Virus Consortium in Europe (RESCEU) birth cohort study: defining the burden of infant respiratory syncytial virus disease in Europe
  gan: Wildenbeest, JG, et al.
  Cyhoeddwyd: (2020)
• Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: Protocol for an observational multicenter, case-control study from the Respiratory Syncytial Virus Consortium in Europe (RESCEU)
  gan: Jefferies, K, et al.
  Cyhoeddwyd: (2020)
• Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection
  gan: McGinley, JP, et al.
  Cyhoeddwyd: (2022)